Dear BOPA Members, The EDQM (the European Directorate for the Quality of Medicines&Healthcare of the Council of Europe) is conducting a survey following a study from national monitoring activities, which…
From prediction to practice: mitigating bias and data shift in machine-learning models for chemotherapy-induced organ dysfunction across unseen cancers New Publication by BOPA Member and AI Specialist Advisory Group (SAG)…
Dear All, I am happy to inform you that the MPN consent forms have been reviewed and updated. Furthermore, a new consent form has been added form for Nivolumab with…
The next episode of Let’s Talk About SACT is Let’s talk about Acute Oncology. In this episode we are joined by Caroline Wilson and Alison Taylor. We discuss what acute…
Dear Member, It has been 12 months since the launch of the “BOPA SACT Verification Passport”. In order to optimise user experience of the Passport, we need to have new…
Dear colleagues, Hypercalcaemia of malignancy is the commonest metabolic complication in cancer patients and there is a lack of evidence in this area, leading to potential variation in clinical practice.…
Dear member, As of the beginning of this month, we have 139 registered sites and 1,600 users subscribed to the SACT verification passport. This is a fabulous uptake and…
A message from the BOPA Immunotherapy SAG: It brings us great pleasure to inform you that the Research & Analysis pillar of the BOPA Immunotherapy SAG has successfully submitted abstract…
Dear BOPA memebers, I am pleased to inform you that consent forms for the following groups have been reviewed and updated 1. Welsh generic adult SACT and immunotherapy…
Do you feel reflected in BOPA’s values, mission and vision? Would you add anything else? Please contact us now – Feedback on the Proposed Vision (office.com) The Vision can be…
The UK Myeloma Society Pharmacy Group (a special-interest group affiliated to BOPA) is running its 2nd Annual Educational Meeting on Tuesday 5th November from 12 Noon to 4.30pm. The meeting…
Dear members, The NIHR-BHF Cardiovascular Partnership theme in Cardio-Oncology is a new project bringing cardiology and oncology specialists together with patient representatives. Its aims are to inform cardio-oncology research priorities,…
